“We want to see AI tech solve neglected diseases.” This bold vision drives Timothy Jenkins, Head of Data Science and Associate Professor at DTU Bioengineering, and it's a mission we're thrilled to spotlight on this week's Data in Biotech. In this episode, Tim shares how his research on AI-guided drug discovery is paving the way for transformative advancements in global health. From developing treatments for neglected tropical diseases to rethinking therapeutic discovery, Tim reveals how AI can revolutionize healthcare access and outcomes. Explore the intersection of AI and biotechnology, and discover how these innovations are creating more effective treatments for underserved communities. Tune in to the conversation wherever you get your podcasts: Apple Podcasts: https://lnkd.in/geYhUpKa Spotify: https://lnkd.in/gNPYtJaU YouTube: https://lnkd.in/g_VXmzbJ #DataInBiotech #ProteinDesign #ComputationalDesign #GlobalHealth
CorrDyn的动态
最相关的动态
-
The future of therapeutic discovery is being redefined by computational methods—but it’s not a straight shot to success. In this week’s podcast, we sit down with Timothy Jenkins of DTU Bioengineering to explore the cutting-edge and the complexities of AI-powered drug discovery. One big insight? Diversity in protein design is critical. Striking the right balance between optimizing performance and mitigating risks opens up new doors, especially for tackling neglected diseases. Discover how computational design methodologies are reshaping drug development and making it more accessible to underserved areas (Link to Nature publication in the comments). Don’t miss this fascinating conversation! ??? To hear the conversation in full, listen here: Apple Podcasts: https://lnkd.in/geYhUpKa Spotify: https://lnkd.in/gNPYtJaU YouTube: https://lnkd.in/g_VXmzbJ #DataInBiotech #ProteinDesign #ComputationalDesign
-
???Exclusive podcast release! Our CEO recently joined Yin He on the latest episode of the AWS Health Innovation Podcast. In this insightful conversation, Andrei Georgescu, Ph.D. delves into how Vivodyne enables human testing before clinical trials. Our innovative platform has the capacity to cultivate tens of thousands of human tissue models at scale, setting a new standard in the field. Key Highlights: ?? How our microfluidic platform revolutionizes drug discovery by providing unprecedented insights into human biology ? The key innovation behind our bottom-up self-assembly approach to grow complex human tissues ?? How our platform aligns with ethical principles by displacing animal testing ?? The immense challenge we are tackling by enabling AI modeling of integrated human physiology ?? Advice from our CEO for biotech entrepreneurs on embracing transformative innovation ... and so much more. ?? Listen on the Health Podcast Network, or wherever you listen to your podcasts:?https://lnkd.in/dJcyhSPA #AWSHealthPod #Biotech #DrugDiscovery #MicrofluidicTechnology #HumanBiology #EthicalInnovation #BiotechStartup #DrugDevelopment #OrganOnAChip
-
Conference Catch-Up: BIO-Europe 2024 - Listen now: https://ow.ly/Syzb50UkNSa Biopharma is evolving through collaboration, early-phase deal-making and innovation in precision medicine and AI. At BIO-Europe, Norstella's subject matter experts explored key trends shaping the industry, from market access strategies to sustaining growth through partnerships. In this podcast episode, Izabela Chmielewska, Kevin Grogan, and Natasha Choukkar discuss takeaways – from advancing personalized treatments to tackling the patent cliff – highlighting how Norstella empowers organizations to navigate complexity and drive innovation.
-
-
Curious about what drives Norstella's subject matter experts? Catch our latest conference catch-up podcast following #BIOEurope for an insightful conversation with Kevin Grogan and Natasha Choukkar. Dive into their perspectives on navigating the complexities and innovations shaping the #biopharma space!
Conference Catch-Up: BIO-Europe 2024 - Listen now: https://ow.ly/Syzb50UkNSa Biopharma is evolving through collaboration, early-phase deal-making and innovation in precision medicine and AI. At BIO-Europe, Norstella's subject matter experts explored key trends shaping the industry, from market access strategies to sustaining growth through partnerships. In this podcast episode, Izabela Chmielewska, Kevin Grogan, and Natasha Choukkar discuss takeaways – from advancing personalized treatments to tackling the patent cliff – highlighting how Norstella empowers organizations to navigate complexity and drive innovation.
-
-
High Performance Coach ?? Author 30 Days To Happiness?? Achieve Your Goals 10 X Faster & Make 2025 The Best Year Of Your Life. DM me ‘2025’ To Learn More About Our Formula??
???????? ?????????? ?????? ???????????? ???????? ???????? ?????? ?????????? Imagine a technology that can analyze your speech and predict over 6,000 diseases. That’s what vocal biomarker technology is doing right now. By using machine learning and AI, this revolutionary approach transforms healthcare—unlocking insights hidden in our speech patterns. From early disease detection to personalized treatments, the future of diagnostics could be as simple as a conversation. Want to learn more about how this works? I dive into it all on my latest podcast episode - https://lnkd.in/g6H-GChs. I interviewed the amazing @danieltolson! ?? Listen now to discover how to become a better human and leader! #Habits #Podcast #Happiness #30DaysToHappiness?
-
Great podcast covering drug development and how we want to make an impact with Dash Bio
We've got a very exciting episode of Data in Biotech to share. Ross Katz sat down with Dave Johnson - former Chief Data and Artificial Intelligence Officer at Moderna and now CEO and Co-founder of Dash Bio - to talk about how his new venture is set to revolutionize clinical bioanalysis and streamline drug development. Dave takes us back to the early research days in Moderna, where he helped lay the groundwork for mRNA technology, which later enabled the development of a vaccine for COVID-19 at unprecedented speed. He also highlights what he sees as the most impactful insufficiencies in drug development—particularly the lack of industrialization and standardization— and how Dash Bio aims to address these issues. The goal— he tells us—is ultimately to develop a more efficient, high-quality end-to-end system and improve the overall efficacy of the drug development process. Ross and Dave also touch upon Dave’s vision for the future of Dash Bio, plus his advice for aspiring biotech data leaders eager to contribute to industry transformation. Listen wherever you get your podcasts. Apple: https://lnkd.in/d8BDwZ9Q Spotify: https://lnkd.in/dtG7GRRK #DataInBiotech #BiotechInnovation #DrugDevelopment #podcast
-
-
“Reducing Hallucinations and Streamlining Drug Discovery Workflows with Generative AI - with Asif Hasan of Quantiphi” https://lnkd.in/gQQYBEba Join Emerj as we welcome Asif Hasan, Co-founder of Quantiphi, as our inaugural guest on our new ‘AI in Healthcare and Life Sciences’ podcast channel. Quantiphi is an AI-first digital engineering firm renowned for crafting AI solutions that significantly impact various sectors. During this engaging discussion with Daniel Faggella, CEO and Head of Research at Emerj, Asif explores crucial developments like minimizing hallucinations in healthcare AI models and enhancing drug discovery processes, particularly for rare diseases. #AI #Healthcare #LifeSciences #Quantiphi #DigitalEngineering #ArtificialIntelligence #Innovation #Technology #Podcast #Emerj #DrugDiscovery #RareDisorders #HealthTech #AIApplications #IndustrySolutions
-
?? New podcast coming soon! ?? Just wrapped up an insightful discussion with my colleague Tobias Corne and Jonas Mareen on the latest advancements in cell therapies! ?? We talk about the cutting-edge innovations, breakthroughs, challenges and future directions. The AI-driven mynd software helped us to have a quick yet comprehensive picture of the domain topics, trends and early signals. Discover the first key insights below. ?? Podcast will be ready soon on our website https://creax.com/. Whether you're a fellow innovator, a healthcare enthusiast, or just curious about the future of medicine, this episode is packed with valuable insights. Don’t miss out! Thanks to Simon Desnerck, Bart Tienpont for the support in podcast preparation. ?? #CellTherapies #Innovation #Healthcare #Podcast #Biotech #Creax #Mynd #Research #AI
-
In the latest episode of the Formidable Podcast, we spoke with Yin Ho, a leader in the biotechnology and health care space, who shared her take on the opportunities and limits of artificial intelligence in medicine. #healthcareAI #AImedicine #womenleaders
-
Thank you Emily Parkhurst for the opportunity to speak on the Formidable podcast. I truly enjoyed it!? Hopefully my point came across that we should not forget about the power of human capabilities. When it comes to complex problem-solving, utilizing AI is not always cost effective nor practical: AI uses a great deal of energy, but it also takes enormous effort on the part of humans to train and teach it. Plus, we don’t always trust the output without additional validation.? Applying AI in a thoughtful manner also means staying mindful about our expectations of what AI can and should do.? Let’s not forget that human capabilities are also worth investing in and are often still the most cost-effective – and sometimes more effective – way to solve complex problems.??
In the latest episode of the Formidable Podcast, we spoke with Yin Ho, a leader in the biotechnology and health care space, who shared her take on the opportunities and limits of artificial intelligence in medicine. #healthcareAI #AImedicine #womenleaders
